Lioresal: Targeted Spasticity Relief for Improved Mobility and Comfort
Lioresal
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.87 | $52.00 (0%) | 🛒 Add to cart |
| 90 | $0.80 | $78.00 $72.00 (8%) | 🛒 Add to cart |
| 120 | $0.77 | $104.00 $92.00 (12%) | 🛒 Add to cart |
| 180 | $0.72 | $156.00 $130.00 (17%) | 🛒 Add to cart |
| 270 | $0.70 | $234.00 $190.00 (19%) | 🛒 Add to cart |
| 360 | $0.69
Best per pill | $312.00 $249.00 (20%) | 🛒 Add to cart |
| Product dosage: 25mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.53 | $76.00 (0%) | 🛒 Add to cart |
| 60 | $2.12 | $152.00 $127.00 (16%) | 🛒 Add to cart |
| 90 | $1.97 | $228.00 $177.00 (22%) | 🛒 Add to cart |
| 120 | $1.89 | $304.00 $227.00 (25%) | 🛒 Add to cart |
| 180 | $1.82 | $456.00 $328.00 (28%) | 🛒 Add to cart |
| 270 | $1.77
Best per pill | $684.00 $478.00 (30%) | 🛒 Add to cart |
Synonyms | |||
Lioresal (baclofen) is a centrally-acting skeletal muscle relaxant specifically indicated for the management of spasticity. It is a gamma-aminobutyric acid (GABA) derivative that acts as an agonist at GABA-B receptors, primarily at the spinal cord level, to inhibit monosynaptic and polysynaptic reflex transmission. This pharmacological action makes it a cornerstone therapy for patients experiencing the disabling muscle spasms, clonus, and pain associated with conditions like multiple sclerosis, spinal cord injuries, and other spinal pathologies. By reducing heightened muscle tone, Lioresal facilitates easier movement, improves comfort, and aids in the execution of physical therapy and activities of daily living, thereby significantly enhancing the quality of life for affected individuals.
Features
- Active Pharmaceutical Ingredient: Baclofen.
- Pharmacologic Class: Gamma-aminobutyric acid (GABA) derivative; centrally-acting skeletal muscle relaxant.
- Primary Mechanism of Action: Agonist activity at GABA-B receptors, leading to the suppression of excitatory neurotransmitter release.
- Administration: Available in oral tablet formulations (10 mg and 20 mg) and an intrathecal solution for delivery via an implanted pump.
- Bioavailability: Rapidly and extensively absorbed from the gastrointestinal tract following oral administration.
- Onset of Action: Oral formulation typically produces effects within 1-2 hours post-ingestion.
- Half-life: Average plasma elimination half-life is approximately 3-4 hours.
- Metabolism: Primarily metabolized hepatically via deamination.
- Excretion: Predominantly eliminated by the kidneys in unchanged form (70-80%) and as metabolites.
Benefits
- Significant Reduction in Muscle Hypertonia: Effectively decreases the frequency and severity of painful muscle spasms and clonus, allowing for greater voluntary control.
- Enhanced Functional Capacity: By alleviating spasticity, it can improve range of motion, facilitate nursing care, and enable more effective participation in physiotherapy and rehabilitation programs.
- Improved Patient Comfort and Quality of Life: Reduces the pain and discomfort associated with chronic spasticity, leading to better sleep and overall daily functioning.
- Flexible Administration Routes: The availability of both oral and intrathecal delivery systems allows for tailored treatment strategies, from moderate to severe, intractable cases.
- Well-Established Efficacy and Safety Profile: As a long-standing first-line therapy, its effects and management are well-documented in clinical literature.
Common use
Lioresal is primarily prescribed for the management of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. It is also indicated for patients with spinal cord injuries and other spinal cord diseases, such as transverse myelitis and amyotrophic lateral sclerosis (ALS). Its use is targeted at individuals for whom spasticity causes significant functional impairment, discomfort, or interference with daily activities or sleep. It is not indicated for the treatment of skeletal muscle spasm resulting from rheumatic disorders.
Dosage and direction
Dosage must be individualized for each patient. Therapy should be started at a low dosage and increased gradually to achieve an optimal effect.
- Initial Adult Dose: 5 mg administered orally three times a day.
- Dosage Titration: The dosage may be increased by 5 mg per dose every three days to a maximum of 80 mg daily (20 mg q.i.d.), based on patient response and tolerability.
- Usual Maintenance Dose: The optimal therapeutic dose typically ranges from 40-80 mg daily, divided into three or four doses.
- Dosing in Renal Impairment: Dose reduction is necessary. Consult prescribing information for specific creatinine clearance-based adjustments.
- Intrathecal Administration: Dosing for the intrathecal formulation is entirely different and is initiated and managed exclusively by physicians experienced in implantable pump systems. It involves a screening phase and continuous infusion via a programmable pump.
- Administration: Tablets should be taken with a glass of water, with or without food, though taking with food may minimize potential gastrointestinal upset.
Precautions
- Abrupt Discontinuation: Abrupt withdrawal of Lioresal, especially after long-term use or high doses, can precipitate a withdrawal syndrome including hallucinations, seizures, and rebound severe spasticity. Dosage must be tapered gradually under medical supervision.
- Exacerbation of Seizures: Use with caution in patients with a history of seizures or EEG abnormalities, as deterioration in seizure control has been reported.
- Renal Impairment: Since baclofen is primarily excreted unchanged by the kidneys, patients with impaired renal function require significant dose reductions and careful monitoring.
- Stroke Patients: Caution is advised in patients who have had a stroke, as the drug’s efficacy in this population is not well-established, and it may cause sedation and motor weakness, potentially masking signs of a recurring CVA.
- Psychiatric and Cognitive Effects: May cause drowsiness, sedation, confusion, and mood disturbances. Patients should be cautioned about operating machinery or driving until their response is known.
- Autonomic Dysreflexia: In patients with spinal cord injuries at T6 or above, Lioresal may mask the symptoms of autonomic dysreflexia.
Contraindications
Lioresal is contraindicated in patients with a known hypersensitivity to baclofen or any component of the formulation.
Possible side effect
The most common side effects are transient and primarily related to the central nervous system. Their incidence is often dose-related.
- Very Common (>10%): Drowsiness, dizziness, weakness, fatigue.
- Common (1-10%): Headache, insomnia, nausea, constipation, hypotension, confusion, euphoria, ataxia.
- Uncommon (0.1-1%): Dry mouth, urinary frequency, blurred vision, rash, depression, hallucinations, paresthesia, tinnitus, erectile dysfunction.
- Rare (<0.1%): Seizures (especially on withdrawal), dyspnea, syncope, chest pain, severe hypotension, elevated liver enzymes, anaphylactic reactions.
Drug interaction
Concomitant use of Lioresal with other CNS depressants can lead to additive sedative effects.
- CNS Depressants (e.g., Alcohol, Benzodiazepines, Opioids, Sedating Antihistamines, Tricyclic Antidepressants): Increased risk of significant drowsiness, sedation, dizziness, and respiratory depression.
- Antihypertensives: May potentiate the blood-pressure-lowering effects, leading to hypotension.
- Levodopa/Carbidopa: Reports of worsened mental confusion, hallucinations, and agitation.
- MAO Inhibitors: May increase the CNS depressant and cardiovascular effects of baclofen.
Missed dose
If a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped. The patient should not double the next dose to “make up” for the missed one, as this increases the risk of side effects.
Overdose
Overdose manifests as a profound exaggeration of its known pharmacological effects.
- Signs and Symptoms: Severe drowsiness progressing to coma, lethargy, seizures, hypotonia, hyporeflexia, respiratory depression, bradycardia, hypotension, hypothermia, vomiting, and salivation.
- Management: There is no specific antidote. Management is primarily supportive and symptomatic. This includes securing the airway, ensuring adequate ventilation, and maintaining cardiovascular function. Gastric lavage or activated charcoal may be considered if ingestion was recent. Hemodialysis may be beneficial in removing the drug, especially in patients with renal impairment. Seizures may be treated with benzodiazepines.
Storage
- Store at room temperature between 20°C to 25°C (68°F to 77°F). Excursions are permitted between 15°C and 30°C (59°F and 86°F).
- Protect from light and moisture.
- Keep the medication in its original container, tightly closed.
- Keep all medications out of the reach of children and pets.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting or altering any treatment regimen. Never disregard professional medical advice or delay in seeking it because of something you have read here.
Reviews
“After my spinal cord injury, the constant spasms in my legs were unbearable and made physiotherapy nearly impossible. Starting Lioresal was a turning point. The titration process was slow, but we found a dose that significantly reduces the spasms without excessive drowsiness. I can now participate fully in my rehab sessions.” – M.S., 42
“As a neurologist treating MS patients for over two decades, baclofen remains a fundamental tool. Its efficacy in managing flexor spasms and associated pain is well-proven. The key is careful, slow titration and patient education about the risks of abrupt withdrawal. For severe, localized spasticity, the intrathecal delivery system is a game-changer.” – Dr. E.R., Neurologist
“The drowsiness was intense for the first two weeks, and I almost stopped. My doctor encouraged me to push through, and I’m glad I did. The side effects subsided, and the relief from the tightness and pain in my muscles has given me a much better quality of life. It’s not perfect, but it makes a significant difference.” – J.K., 58